HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yingli Wang Selected Research

Acrocephalosyndactylia (Apert Syndrome)

5/2013From shape to cells: mouse models reveal mechanisms altering palate development in Apert syndrome.
1/2013Novel molecular pathways elicited by mutant FGFR2 may account for brain abnormalities in Apert syndrome.
11/2010Beyond the closed suture in apert syndrome mouse models: evidence of primary effects of FGFR2 signaling on facial shape at birth.
3/2010Brain phenotypes in two FGFR2 mouse models for Apert syndrome.
2/2010Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice.
7/2008The study of abnormal bone development in the Apert syndrome Fgfr2+/S252W mouse using a 3D hydrogel culture model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yingli Wang Research Topics

Disease

18Neoplasms (Cancer)
10/2022 - 07/2010
6Acrocephalosyndactylia (Apert Syndrome)
05/2013 - 07/2008
5Craniosynostoses (Craniosynostosis)
01/2013 - 07/2008
3Breast Neoplasms (Breast Cancer)
10/2019 - 11/2017
2Ischemic Stroke
03/2022 - 01/2022
2Infarction (Infarctions)
01/2022 - 01/2018
2Brain Ischemia (Cerebral Ischemia)
01/2022 - 01/2018
2Cognitive Dysfunction
01/2022 - 01/2011
2Neoplasm Metastasis (Metastasis)
10/2021 - 11/2018
2Carcinogenesis
07/2018 - 10/2012
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018 - 01/2016
2Obesity
04/2015 - 01/2011
2Hepatocellular Carcinoma (Hepatoma)
12/2013 - 10/2012
2Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
05/2013 - 11/2010
2Synostosis
03/2010 - 02/2010
1Memory Disorders (Memory Loss)
10/2022
1Amnesia (Dissociative Amnesia)
10/2022
1Triple Negative Breast Neoplasms
10/2022
1Poisoning
06/2022
1Hemolysis
04/2022
1Colitis
04/2022
1Stroke (Strokes)
03/2022
1Reperfusion Injury
01/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022
1Hemiplegia (Spastic Hemiplegia)
01/2022
1Weight Loss (Weight Reduction)
10/2021
1Dementia (Dementias)
10/2021
1Circulating Neoplastic Cells
10/2021
1Hepatitis B
06/2021
1Heart Failure
01/2021
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2021
1Epstein-Barr Virus Infections
01/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2021
1Pheochromocytoma
01/2021
1Paraganglioma (Paragangliomas)
01/2021
1Cardiomyopathies (Cardiomyopathy)
01/2021
1Myocardial Infarction
01/2021
1Glioma (Gliomas)
12/2020
1Cardiotoxicity
09/2020
1Postoperative Pain
02/2020

Drug/Important Bio-Agent (IBA)

7Paclitaxel (Taxol)FDA LinkGeneric
10/2022 - 11/2017
6Liposomes (Liposome)IBA
10/2022 - 12/2019
6Pharmaceutical PreparationsIBA
10/2022 - 11/2017
5ProdrugsIBA
10/2022 - 11/2017
5Doxorubicin (Adriamycin)FDA LinkGeneric
10/2022 - 10/2012
4Proteins (Proteins, Gene)FDA Link
12/2020 - 12/2010
4Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
05/2013 - 07/2008
3Biological ProductsIBA
10/2021 - 07/2018
3Protein Kinases (Protein Kinase)IBA
12/2013 - 07/2010
3Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2013 - 03/2010
2Therapeutic UsesIBA
04/2022 - 01/2022
2EpitopesIBA
06/2021 - 01/2021
2AntioxidantsIBA
12/2020 - 04/2015
2MicroRNAs (MicroRNA)IBA
07/2018 - 01/2018
2Glucose (Dextrose)FDA LinkGeneric
01/2016 - 07/2010
1PowdersIBA
10/2022
1chromium hexavalent ionIBA
06/2022
1Anti-Bacterial Agents (Antibiotics)IBA
04/2022
1mijianchangpuIBA
03/2022
1JBP 923IBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022
1OligopeptidesIBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2022
1DipeptidesIBA
01/2022
1Vascular Endothelial Growth Factor CIBA
01/2022
1Glutathione Disulfide (GSSG)FDA LinkGeneric
01/2022
1Yuanzhi SanIBA
01/2022
1Hypoglycemic Agents (Hypoglycemics)IBA
10/2021
1LipidsIBA
10/2021
1TeaIBA
10/2021
1Digoxin (Digitek)FDA LinkGeneric
10/2021
1CalciumIBA
10/2021
1Peptides (Polypeptides)IBA
04/2021
1EnzymesIBA
04/2021
1arginyl-glycyl-aspartic acidIBA
04/2021
1ApoferritinsIBA
04/2021
1AcidsIBA
01/2021
1CatecholaminesIBA
01/2021
1VaccinesIBA
01/2021
1EBV-encoded nuclear antigen 1IBA
01/2021
1Ferritins (Ferritin)IBA
01/2021
1MicellesIBA
12/2020
1ArtemetherFDA Link
12/2020
1Phospholipids (Phosphatides)FDA LinkGeneric
11/2020
1liposomal doxorubicin (Doxil)FDA Link
09/2020
1Irinotecan (Camptosar)FDA LinkGeneric
12/2019
1Amino Acid Transport Systems (Amino Acid Transporter)IBA
12/2019
1Tyrosine (L-Tyrosine)FDA Link
12/2019
1polyethylene glycol oleyl etherIBA
09/2019
1CationsIBA
09/2019
1triphenylphosphoniumIBA
09/2019

Therapy/Procedure

8Therapeutics
01/2022 - 11/2017
5Sutures (Suture)
01/2013 - 02/2010
3Drug Therapy (Chemotherapy)
01/2022 - 10/2018
2Intravenous Injections
01/2019 - 01/2018
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022
1Knee Replacement Arthroplasty (Total Knee Replacement)
02/2020
1Combination Drug Therapy (Combination Chemotherapy)
10/2019
1Lasers (Laser)
01/2019